News
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
Peptides are gaining steam as ways to fight aging, build muscle, and burn fat. Here's what doctors want you to know before you take the shots.
3h
HealthDay on MSNGLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...
Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...
Scientists map how the brain integrates hormonal and neural signals from the body to control appetite, energy use, and reward ...
Findings from key secondary endpoints showed 59.6% of patients taking orforglipron 36 mg (highest dose) achieved a reduction in body weight of 10% or greater vs 8.6% of patients receiving placebo; ...
Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...
Over time, these drugs have also been found to help people lose weight by slowing digestion, reducing hunger, and making ...
With salty snack dollars slumping, leveraging ‘sweet spots’ and navigating the ‘snackscape’ could help regain share ...
Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results